(Q37406558)

20 August 2017

Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration (English)

1 reference

20 August 2017

1 reference

1 reference

5

1 reference

20 August 2017

4

Emily Y Chew

1 reference

20 August 2017

2

Catherine Cukras

1 reference

20 August 2017

Farzin Forooghian

1

1 reference

PMC publication ID

2770842

20 August 2017

Catherine B Meyerle

series ordinal

3

1 reference

20 August 2017

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

29

1 reference

20 August 2017

6

1 reference

20 August 2017

723-731

1 reference

Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Ranibizumab for neovascular age-related macular degeneration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

The epidemiology of age-related macular degeneration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Macrophage depletion inhibits experimental choroidal neovascularization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770842

Pharmacokinetics of intravitreal bevacizumab (Avastin)

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19516114

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19516114

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/IAE.0B013E3181A2C1C3

1 reference

20 August 2017

1 reference

PMC publication ID

2770842

20 August 2017

PubMed publication ID

19516114

1 reference

PMC publication ID

2770842